CochLear Revenue vs. Cash And Equivalents
| CHEOY Stock | USD 92.47 0.60 0.65% |
For CochLear profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CochLear to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CochLear Ltd ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CochLear's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CochLear Ltd ADR over time as well as its relative position and ranking within its peers.
CochLear |
CochLear ADR Cash And Equivalents vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CochLear's current stock value. Our valuation model uses many indicators to compare CochLear value to that of its competitors to determine the firm's financial worth. CochLear Ltd ADR is rated third in revenue category among its peers. It is rated fourth in cash and equivalents category among its peers creating about 0.38 of Cash And Equivalents per Revenue. The ratio of Revenue to Cash And Equivalents for CochLear Ltd ADR is roughly 2.62 . Comparative valuation analysis is a catch-all model that can be used if you cannot value CochLear by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CochLear's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.CochLear Revenue vs. Competition
CochLear Ltd ADR is rated third in revenue category among its peers. Market size based on revenue of Medical Devices industry is currently estimated at about 187.48 Billion. CochLear maintains roughly 1.65 Billion in revenue contributing less than 1% to all equities under Medical Devices industry.
CochLear Cash And Equivalents vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
CochLear |
| = | 1.65 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
CochLear |
| = | 629.3 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CochLear Cash And Equivalents Comparison
CochLear is currently under evaluation in cash and equivalents category among its peers.
CochLear Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CochLear, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CochLear will eventually generate negative long term returns. The profitability progress is the general direction of CochLear's change in net profit over the period of time. It can combine multiple indicators of CochLear, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4500 people.
CochLear Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CochLear. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CochLear position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CochLear's important profitability drivers and their relationship over time.
Use CochLear in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CochLear position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CochLear will appreciate offsetting losses from the drop in the long position's value.CochLear Pair Trading
CochLear Ltd ADR Pair Trading Analysis
The ability to find closely correlated positions to CochLear could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CochLear when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CochLear - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CochLear Ltd ADR to buy it.
The correlation of CochLear is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CochLear moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CochLear ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CochLear can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your CochLear position
In addition to having CochLear in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Makers Thematic Idea Now
Chemicals Makers
Companies developing chemicals for crops, soil as well as human, and animals. The Chemicals Makers theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Makers Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for CochLear Pink Sheet Analysis
When running CochLear's price analysis, check to measure CochLear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CochLear is operating at the current time. Most of CochLear's value examination focuses on studying past and present price action to predict the probability of CochLear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CochLear's price. Additionally, you may evaluate how the addition of CochLear to your portfolios can decrease your overall portfolio volatility.